Related Experiment Videos
Lessons learned from the Sunbelt Melanoma Trial
Kelly M McMasters1, R Dirk Noyes, Douglas S Reintgen
1The Department of Surgery, University of Louisville, James Graham Brown Cancer Center and Center for Advanced Surgical Technologies (CAST), Louisville, Kentucky 40202, USA. kelly.mcmasters@nortonhealthcare.org
Journal of Surgical Oncology
|June 29, 2004
Summary
The Sunbelt Melanoma Trial demonstrates sentinel lymph node biopsy is safe and effective for melanoma staging. Identifying sentinel nodes aids in predicting metastasis and guides treatment decisions for patients.
Area of Science:
- Oncology
- Surgical Oncology
- Dermatology
Background:
- The Sunbelt Melanoma Trial is a large, prospective, randomized study involving over 3600 patients across 79 centers.
- It incorporates molecular staging via reverse transcriptase polymerase chain reaction (RT-PCR), a novel approach in large melanoma trials.
- The study investigates sentinel lymph node (SLN) biopsy and melanoma prognostic factors.
Purpose of the Study:
- To evaluate the safety and efficacy of sentinel lymph node biopsy in melanoma patients.
- To identify prognostic factors for melanoma metastasis and recurrence.
- To assess the utility of molecular staging in melanoma management.
Main Methods:
- Prospective, multicenter, randomized trial design.
- Sentinel lymph node biopsy with radioactive tracer localization.
- Reverse transcriptase polymerase chain reaction (RT-PCR) for molecular staging.
- Analysis of prognostic factors, recurrence patterns, and patient age correlation.
Main Results:
- Sentinel lymph node biopsy has a low rate of postoperative complications compared to complete lymph node dissection.
- Factors predicting the presence of SLN metastases have been identified.
- No factors reliably predict low risk of non-sentinel node metastases in positive SLN cases, supporting completion lymphadenectomy.
- Interval or in-transit sentinel nodes can be the sole site of metastasis.
- Challenges in head and neck melanoma SLN biopsy and early recurrence patterns were evaluated.
- A correlation between increasing patient age and prognostic factors was noted.
Conclusions:
- Sentinel lymph node biopsy is a safe and valuable staging tool for melanoma.
- Completion lymphadenectomy is recommended for patients with positive sentinel nodes.
- Further analyses will focus on therapeutic lymphadenectomy, adjuvant interferon therapy, and molecular staging validation.